Keywords: mixed, 10-year, prospects, five, therapeutic, sectors, japan
Mixed 10-year prospects for five therapeutic sectors in Japan
Article | 03 July 2006
The Japanese market for anti-allergic drugs will witness an 8% fall from 157.1 billion yen ($1.37 billion) in 2005 to 144.0 billion yen in 2014, according ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Elan makes "transformational" acquisitions and a divestment
- Drug prices to plunge as Indian government announces plans to regulate rates of 652 medicines
- SciClone gains China rights to Zensun's Neucardin
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- Boehringer Ingelheim transitions to propellant-free Combivent Respimat; names new BMD member
